By contrast, EGFR exon 20 insertion (ex20ins) mutations comprise a smaller subset of NSCLC and historically have been associated with intrinsic resistance to standard-dose EGFR-TKIs (4–7). This evidence concerns the gene EGFR and non-small cell lung carcinoma.